Clinical Trial Update: A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) [Phase 1, Phase 2]

View source ↗

Summary

This is a clinical trial update for a Phase 1/2 study of NKX019 in immune‑mediated diseases, currently recruiting to assess safety and early efficacy in systemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antineutrophil Cytoplasmic Antibody-associated Vasculitis
• Idiopathic Inflammatory Myopathies
• Systemic Sclerosis

Drugs mentioned

• NKX019

Snippet

Sponsor: Nkarta, Inc. | Conditions: Systemic Sclerosis, Idiopathic Inflammatory Myopathies | Phase 1, Phase 2 | Status: RECRUITING